APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lipid-lowering Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lipid-lowering Drugs Industry Growth and Trends Forecast to 2032

20 December 2025106 pages

Choose your research edition.

Industry ResearchLipid-lowering Drugs Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid-lowering Drugs Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Lipid-lowering Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid-lowering Drugs Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lipid-lowering Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Lipid-lowering Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lipid-lowering Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lipid-lowering Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lipid-lowering Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lipid-lowering Drugs include Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., Sanofi, Novartis AG, Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline plc, Amgen Inc. and AbbVie, Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lipid-lowering Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lipid-lowering Drugs market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lipid-lowering Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lipid-lowering Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Lipid-lowering Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lipid-lowering Drugs Market by Company

Takeda Pharmaceutical Company Limited

Sun Pharmaceutical Industries Ltd.

Sanofi

Novartis AG

Merck & Co., Inc.

Pfizer, Inc.

GlaxoSmithKline plc

Amgen Inc.

AbbVie, Inc.

AstraZeneca PLC

Viatris (Mylan N.V.)

Dr. Reddy’s Laboratories Ltd.

Lipid-lowering Drugs Segment by Type

Statins & Combination

Bile Acid Sequestrants

Cholesterol Absorption Inhibitors

Fibrates

PCSK9 Inhibitors

Others

Lipid-lowering Drugs Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Lipid-lowering Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid-lowering Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid-lowering Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid-lowering Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lipid-lowering Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Lipid-lowering Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Statins & Combination Table 2. Major Company of Bile Acid Sequestrants Table 3. Major Company of Cholesterol Absorption Inhibitors Table 4. Major Company of Fibrates Table 5. Major Company of PCSK9 Inhibitors Table 6. Major Company of Others Table 7. Global Lipid-lowering Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 8. Global Lipid-lowering Drugs Sales by Type (2021-2026) & (k units) Table 9. Global Lipid-lowering Drugs Sales Market Share in Volume by Type (2021-2026) Table 10. Global Lipid-lowering Drugs Sales by Type (2021-2026) & (US$ Million) Table 11. Global Lipid-lowering Drugs Sales Market Share in Value by Type (2021-2026) Table 12. Global Lipid-lowering Drugs Price by Type (2021-2026) & (US$/unit) Table 13. Global Lipid-lowering Drugs Sales by Type (2027-2032) & (k units) Table 14. Global Lipid-lowering Drugs Sales Market Share in Volume by Type (2027-2032) Table 15. Global Lipid-lowering Drugs Sales by Type (2027-2032) & (US$ Million) Table 16. Global Lipid-lowering Drugs Sales Market Share in Value by Type (2027-2032) Table 17. Global Lipid-lowering Drugs Price by Type (2027-2032) & (US$/unit) Table 18. North America Lipid-lowering Drugs Sales by Type (2021-2026) & (k units) Table 19. North America Lipid-lowering Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Europe Lipid-lowering Drugs Sales by Type (2021-2026) & (k units) Table 21. Europe Lipid-lowering Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Asia-Pacific Lipid-lowering Drugs Sales by Type (2021-2026) & (k units) Table 23. Asia-Pacific Lipid-lowering Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Latin America Lipid-lowering Drugs Sales by Type (2021-2026) & (k units) Table 25. Latin America Lipid-lowering Drugs Sales by Type (2021-2026) & (US$ Million) Table 26. Middle East and Africa Lipid-lowering Drugs Sales by Type (2021-2026) & (k units) Table 27. Middle East and Africa Lipid-lowering Drugs Sales by Type (2021-2026) & (US$ Million) Table 28. Lipid-lowering Drugs Industry Trends Table 29. Lipid-lowering Drugs Industry Drivers Table 30. Lipid-lowering Drugs Industry Opportunities and Challenges Table 31. Lipid-lowering Drugs Industry Restraints Table 32. Global Lipid-lowering Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 33. Global Lipid-lowering Drugs Revenue Market Share by Company (2021-2026) Table 34. Global Lipid-lowering Drugs Sales by Company (2021-2026) & (k units) Table 35. Global Lipid-lowering Drugs Sales Share by Company (2021-2026) Table 36. Global Lipid-lowering Drugs Market Price by Company (2021-2026) & (US$/unit) Table 37. Global Lipid-lowering Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 38. Global Lipid-lowering Drugs Major Company Production Sites and Headquarters Table 39. Global Lipid-lowering Drugs Company, Product Type & Application Table 40. Global Lipid-lowering Drugs Company Establishment Date Table 41. Global Company Market Concentration Ratio (CR5 and HHI) Table 42. Global Lipid-lowering Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 43. Global Lipid-lowering Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Lipid-lowering Drugs Sales by Region (2021-2026) & (k units) Table 45. Global Lipid-lowering Drugs Sales Market Share in Volume by Region (2021-2026) Table 46. Global Lipid-lowering Drugs Sales by Region (2021-2026) & (US$ Million) Table 47. Global Lipid-lowering Drugs Sales Market Share in Value by Region (2021-2026) Table 48. Global Lipid-lowering Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 49. Global Lipid-lowering Drugs Sales by Region (2027-2032) & (k units) Table 50. Global Lipid-lowering Drugs Sales Market Share in Volume by Region (2027-2032) Table 51. Global Lipid-lowering Drugs Sales by Region (2027-2032) & (US$ Million) Table 52. Global Lipid-lowering Drugs Sales Market Share in Value by Region (2027-2032) Table 53. Global Lipid-lowering Drugs Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 54. Global Lipid-lowering Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 55. Global Lipid-lowering Drugs Sales by Application (2021-2026) & (k units) Table 56. Global Lipid-lowering Drugs Sales Market Share in Volume by Application (2021-2026) Table 57. Global Lipid-lowering Drugs Sales by Application (2021-2026) & (US$ Million) Table 58. Global Lipid-lowering Drugs Sales Market Share in Value by Application (2021-2026) Table 59. Global Lipid-lowering Drugs Price by Application (2021-2026) & (US$/unit) Table 60. Global Lipid-lowering Drugs Sales by Application (2027-2032) & (k units) Table 61. Global Lipid-lowering Drugs Sales Market Share in Volume by Application (2027-2032) Table 62. Global Lipid-lowering Drugs Sales by Application (2027-2032) & (US$ Million) Table 63. Global Lipid-lowering Drugs Sales Market Share in Value by Application (2027-2032) Table 64. Global Lipid-lowering Drugs Price by Application (2027-2032) & (US$/unit) Table 65. North America Lipid-lowering Drugs Sales by Application (2021-2026) & (k units) Table 66. North America Lipid-lowering Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Europe Lipid-lowering Drugs Sales by Application (2021-2026) & (k units) Table 68. Europe Lipid-lowering Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Asia-Pacific Lipid-lowering Drugs Sales by Application (2021-2026) & (k units) Table 70. Asia-Pacific Lipid-lowering Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Latin America Lipid-lowering Drugs Sales by Application (2021-2026) & (k units) Table 72. Latin America Lipid-lowering Drugs Sales by Application (2021-2026) & (US$ Million) Table 73. Middle East and Africa Lipid-lowering Drugs Sales by Application (2021-2026) & (k units) Table 74. Middle East and Africa Lipid-lowering Drugs Sales by Application (2021-2026) & (US$ Million) Table 75. Takeda Pharmaceutical Company Limited Company Information Table 76. Takeda Pharmaceutical Company Limited Business Overview Table 77. Takeda Pharmaceutical Company Limited Lipid-lowering Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 78. Takeda Pharmaceutical Company Limited Lipid-lowering Drugs Product Portfolio Table 79. Takeda Pharmaceutical Company Limited Recent Development Table 80. Sun Pharmaceutical Industries Ltd. Company Information Table 81. Sun Pharmaceutical Industries Ltd. Business Overview Table 82. Sun Pharmaceutical Industries Ltd. Lipid-lowering Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 83. Sun Pharmaceutical Industries Ltd. Lipid-lowering Drugs Product Portfolio Table 84. Sun Pharmaceutical Industries Ltd. Recent Development Table 85. Sanofi Company Information Table 86. Sanofi Business Overview Table 87. Sanofi Lipid-lowering Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 88. Sanofi Lipid-lowering Drugs Product Portfolio Table 89. Sanofi Recent Development Table 90. Novartis AG Company Information Table 91. Novartis AG Business Overview Table 92. Novartis AG Lipid-lowering Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 93. Novartis AG Lipid-lowering Drugs Product Portfolio Table 94. Novartis AG Recent Development Table 95. Merck & Co., Inc. Company Information Table 96. Merck & Co., Inc. Business Overview Table 97. Merck & Co., Inc. Lipid-lowering Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 98. Merck & Co., Inc. Lipid-lowering Drugs Product Portfolio Table 99. Merck & Co., Inc. Recent Development Table 100. Pfizer, Inc. Company Information Table 101. Pfizer, Inc. Business Overview Table 102. Pfizer, Inc. Lipid-lowering Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 103. Pfizer, Inc. Lipid-lowering Drugs Product Portfolio Table 104. Pfizer, Inc. Recent Development Table 105. GlaxoSmithKline plc Company Information Table 106. GlaxoSmithKline plc Business Overview Table 107. GlaxoSmithKline plc Lipid-lowering Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 108. GlaxoSmithKline plc Lipid-lowering Drugs Product Portfolio Table 109. GlaxoSmithKline plc Recent Development Table 110. Amgen Inc. Company Information Table 111. Amgen Inc. Business Overview Table 112. Amgen Inc. Lipid-lowering Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 113. Amgen Inc. Lipid-lowering Drugs Product Portfolio Table 114. Amgen Inc. Recent Development Table 115. AbbVie, Inc. Company Information Table 116. AbbVie, Inc. Business Overview Table 117. AbbVie, Inc. Lipid-lowering Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 118. AbbVie, Inc. Lipid-lowering Drugs Product Portfolio Table 119. AbbVie, Inc. Recent Development Table 120. AstraZeneca PLC Company Information Table 121. AstraZeneca PLC Business Overview Table 122. AstraZeneca PLC Lipid-lowering Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 123. AstraZeneca PLC Lipid-lowering Drugs Product Portfolio Table 124. AstraZeneca PLC Recent Development Table 125. Viatris (Mylan N.V.) Company Information Table 126. Viatris (Mylan N.V.) Business Overview Table 127. Viatris (Mylan N.V.) Lipid-lowering Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 128. Viatris (Mylan N.V.) Lipid-lowering Drugs Product Portfolio Table 129. Viatris (Mylan N.V.) Recent Development Table 130. Dr. Reddy’s Laboratories Ltd. Company Information Table 131. Dr. Reddy’s Laboratories Ltd. Business Overview Table 132. Dr. Reddy’s Laboratories Ltd. Lipid-lowering Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 133. Dr. Reddy’s Laboratories Ltd. Lipid-lowering Drugs Product Portfolio Table 134. Dr. Reddy’s Laboratories Ltd. Recent Development Table 135. North America Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 136. North America Lipid-lowering Drugs Sales by Country (2021-2026) & (k units) Table 137. North America Lipid-lowering Drugs Sales Market Share by Country (2021-2026) Table 138. North America Lipid-lowering Drugs Sales Forecast by Country (2027-2032) & (k units) Table 139. North America Lipid-lowering Drugs Sales Market Share Forecast by Country (2027-2032) Table 140. North America Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 141. North America Lipid-lowering Drugs Market Size by Country (2021-2026) & (US$ Million) Table 142. North America Lipid-lowering Drugs Market Share by Country (2021-2026) Table 143. North America Lipid-lowering Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 144. North America Lipid-lowering Drugs Market Share Forecast by Country (2027-2032) Table 145. Europe Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 146. Europe Lipid-lowering Drugs Sales by Country (2021-2026) & (k units) Table 147. Europe Lipid-lowering Drugs Sales Market Share by Country (2021-2026) Table 148. Europe Lipid-lowering Drugs Sales Forecast by Country (2027-2032) & (k units) Table 149. Europe Lipid-lowering Drugs Sales Market Share Forecast by Country (2027-2032) Table 150. Europe Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 151. Europe Lipid-lowering Drugs Market Size by Country (2021-2026) & (US$ Million) Table 152. Europe Lipid-lowering Drugs Market Share by Country (2021-2026) Table 153. Europe Lipid-lowering Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 154. Europe Lipid-lowering Drugs Market Share Forecast by Country (2027-2032) Table 155. Asia-Pacific Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 156. Asia-Pacific Lipid-lowering Drugs Sales by Country (2021-2026) & (k units) Table 157. Asia-Pacific Lipid-lowering Drugs Sales Market Share by Country (2021-2026) Table 158. Asia-Pacific Lipid-lowering Drugs Sales Forecast by Country (2027-2032) & (k units) Table 159. Asia-Pacific Lipid-lowering Drugs Sales Market Share Forecast by Country (2027-2032) Table 160. Asia-Pacific Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 161. Asia-Pacific Lipid-lowering Drugs Market Size by Country (2021-2026) & (US$ Million) Table 162. Asia-Pacific Lipid-lowering Drugs Market Share by Country (2021-2026) Table 163. Asia-Pacific Lipid-lowering Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 164. Asia-Pacific Lipid-lowering Drugs Market Share Forecast by Country (2027-2032) Table 165. Latin America Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 166. Latin America Lipid-lowering Drugs Sales by Country (2021-2026) & (k units) Table 167. Latin America Lipid-lowering Drugs Sales Market Share by Country (2021-2026) Table 168. Latin America Lipid-lowering Drugs Sales Forecast by Country (2027-2032) & (k units) Table 169. Latin America Lipid-lowering Drugs Sales Market Share Forecast by Country (2027-2032) Table 170. Latin America Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 171. Latin America Lipid-lowering Drugs Market Size by Country (2021-2026) & (US$ Million) Table 172. Latin America Lipid-lowering Drugs Market Share by Country (2021-2026) Table 173. Latin America Lipid-lowering Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 174. Latin America Lipid-lowering Drugs Market Share Forecast by Country (2027-2032) Table 175. Middle East and Africa Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 176. Middle East and Africa Lipid-lowering Drugs Sales by Country (2021-2026) & (k units) Table 177. Middle East and Africa Lipid-lowering Drugs Sales Market Share by Country (2021-2026) Table 178. Middle East and Africa Lipid-lowering Drugs Sales Forecast by Country (2027-2032) & (k units) Table 179. Middle East and Africa Lipid-lowering Drugs Sales Market Share Forecast by Country (2027-2032) Table 180. Middle East and Africa Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 181. Middle East and Africa Lipid-lowering Drugs Market Size by Country (2021-2026) & (US$ Million) Table 182. Middle East and Africa Lipid-lowering Drugs Market Share by Country (2021-2026) Table 183. Middle East and Africa Lipid-lowering Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 184. Middle East and Africa Lipid-lowering Drugs Market Share Forecast by Country (2027-2032) Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. Lipid-lowering Drugs Distributors List Table 188. Lipid-lowering Drugs Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. Lipid-lowering Drugs Image Figure 2. Global Lipid-lowering Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lipid-lowering Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Lipid-lowering Drugs Sales (2021-2032) & (k units) Figure 5. Statins & Combination Image Figure 6. Global Statins & Combination Sales YoY Growth (2021-2032) & (k units) Figure 7. Bile Acid Sequestrants Image Figure 8. Global Bile Acid Sequestrants Sales YoY Growth (2021-2032) & (k units) Figure 9. Cholesterol Absorption Inhibitors Image Figure 10. Global Cholesterol Absorption Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 11. Fibrates Image Figure 12. Global Fibrates Sales YoY Growth (2021-2032) & (k units) Figure 13. PCSK9 Inhibitors Image Figure 14. Global PCSK9 Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 15. Others Image Figure 16. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 17. Global Lipid-lowering Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 18. Global Lipid-lowering Drugs Market Share by Type 2025 VS 2032 Figure 19. North America Lipid-lowering Drugs Sales Market Share in Volume by Type in 2025 Figure 20. North America Lipid-lowering Drugs Sales Market Share in Value by Type in 2025 Figure 21. Europe Lipid-lowering Drugs Sales Market Share in Volume by Type in 2025 Figure 22. Europe Lipid-lowering Drugs Sales Market Share in Value by Type in 2025 Figure 23. Asia-Pacific Lipid-lowering Drugs Sales Market Share in Volume by Type in 2025 Figure 24. Asia-Pacific Lipid-lowering Drugs Sales Market Share in Value by Type in 2025 Figure 25. Latin America Lipid-lowering Drugs Sales Market Share in Volume by Type in 2025 Figure 26. Latin America Lipid-lowering Drugs Sales Market Share in Value by Type in 2025 Figure 27. Middle East and Africa Lipid-lowering Drugs Sales Market Share in Volume by Type in 2025 Figure 28. Middle East and Africa Lipid-lowering Drugs Sales Market Share in Value by Type in 2025 Figure 29. Global Top 5 and 10 Lipid-lowering Drugs Players Market Share by Revenue in 2025 Figure 30. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Hospital Pharmacies Image Figure 32. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 33. Online Pharmacies Image Figure 34. Global Online Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 35. Retail Pharmacies Image Figure 36. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (k units) Figure 37. Global Lipid-lowering Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Lipid-lowering Drugs Market Share by Application 2025 VS 2032 Figure 39. North America Lipid-lowering Drugs Sales Market Share in Volume by Application in 2025 Figure 40. North America Lipid-lowering Drugs Sales Market Share in Value by Application in 2025 Figure 41. Europe Lipid-lowering Drugs Sales Market Share in Volume by Application in 2025 Figure 42. Europe Lipid-lowering Drugs Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Lipid-lowering Drugs Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Lipid-lowering Drugs Sales Market Share in Value by Application in 2025 Figure 45. Latin America Lipid-lowering Drugs Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Lipid-lowering Drugs Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Lipid-lowering Drugs Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Lipid-lowering Drugs Sales Market Share in Value by Application in 2025 Figure 49. North America Lipid-lowering Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. North America Lipid-lowering Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Lipid-lowering Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Lipid-lowering Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Lipid-lowering Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Europe Lipid-lowering Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Lipid-lowering Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Lipid-lowering Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Lipid-lowering Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Asia-Pacific Lipid-lowering Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Lipid-lowering Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Lipid-lowering Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Lipid-lowering Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Latin America Lipid-lowering Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Lipid-lowering Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Lipid-lowering Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Lipid-lowering Drugs Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 66. Middle East and Africa Lipid-lowering Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Lipid-lowering Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Lipid-lowering Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Lipid-lowering Drugs Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Lipid-lowering Drugs Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Statins & Combination
  • Bile Acid Sequestrants
  • Cholesterol Absorption Inhibitors
  • Fibrates
  • PCSK9 Inhibitors
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Takeda Pharmaceutical Company Limited
  • Sun Pharmaceutical Industries Ltd.
  • Sanofi
  • Novartis AG
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • GlaxoSmithKline plc
  • Amgen Inc.
  • AbbVie, Inc.
  • AstraZeneca PLC
  • Viatris (Mylan N.V.)
  • Dr. Reddy’s Laboratories Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Lipid-lowering Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Lipid-lowering Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Lipid-lowering Drugs Market by Type
  6. 1.3.1 Statins & Combination
  7. 1.3.2 Bile Acid Sequestrants
  8. 1.3.3 Cholesterol Absorption Inhibitors
  9. 1.3.4 Fibrates
  10. 1.3.5 PCSK9 Inhibitors
  11. 1.3.6 Others
  12. 1.4 Global Lipid-lowering Drugs Market Size by Type
  13. 1.4.1 Global Lipid-lowering Drugs Market Size Overview by Type (2021-2032)
  14. 1.4.2 Global Lipid-lowering Drugs Historic Market Size Review by Type (2021-2026)
  15. 1.4.3 Global Lipid-lowering Drugs Forecasted Market Size by Type (2027-2032)
  16. 1.5 Key Regions Market Size by Type
  17. 1.5.1 North America Lipid-lowering Drugs Sales Breakdown by Type (2021-2026)
  18. 1.5.2 Europe Lipid-lowering Drugs Sales Breakdown by Type (2021-2026)
  19. 1.5.3 Asia-Pacific Lipid-lowering Drugs Sales Breakdown by Type (2021-2026)
  20. 1.5.4 South America Lipid-lowering Drugs Sales Breakdown by Type (2021-2026)
  21. 1.5.5 Middle East and Africa Lipid-lowering Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Lipid-lowering Drugs Industry Trends
  2. 2.2 Lipid-lowering Drugs Industry Drivers
  3. 2.3 Lipid-lowering Drugs Industry Opportunities and Challenges
  4. 2.4 Lipid-lowering Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Lipid-lowering Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Lipid-lowering Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Lipid-lowering Drugs Price (2021-2026)
  4. 3.4 Global Lipid-lowering Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lipid-lowering Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Lipid-lowering Drugs Company, Product Type & Application
  7. 3.7 Global Lipid-lowering Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lipid-lowering Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lipid-lowering Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lipid-lowering Drugs Tier 1, Tier 2, and Tier 3
4 Lipid-lowering Drugs Regional Status and Outlook
  1. 4.1 Global Lipid-lowering Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Lipid-lowering Drugs Historic Market Size by Region
  3. 4.2.1 Global Lipid-lowering Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Lipid-lowering Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Lipid-lowering Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Lipid-lowering Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Lipid-lowering Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Lipid-lowering Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Lipid-lowering Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Lipid-lowering Drugs by Application
  1. 5.1 Lipid-lowering Drugs Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Lipid-lowering Drugs Market Size by Application
  6. 5.2.1 Global Lipid-lowering Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Lipid-lowering Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Lipid-lowering Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Lipid-lowering Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Lipid-lowering Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Lipid-lowering Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Lipid-lowering Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Lipid-lowering Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Takeda Pharmaceutical Company Limited
  2. 6.1.1 Takeda Pharmaceutical Company Limited Company Information
  3. 6.1.2 Takeda Pharmaceutical Company Limited Business Overview
  4. 6.1.3 Takeda Pharmaceutical Company Limited Lipid-lowering Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Pharmaceutical Company Limited Lipid-lowering Drugs Product Portfolio
  6. 6.1.5 Takeda Pharmaceutical Company Limited Recent Developments
  7. 6.2 Sun Pharmaceutical Industries Ltd.
  8. 6.2.1 Sun Pharmaceutical Industries Ltd. Company Information
  9. 6.2.2 Sun Pharmaceutical Industries Ltd. Business Overview
  10. 6.2.3 Sun Pharmaceutical Industries Ltd. Lipid-lowering Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sun Pharmaceutical Industries Ltd. Lipid-lowering Drugs Product Portfolio
  12. 6.2.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  13. 6.3 Sanofi
  14. 6.3.1 Sanofi Company Information
  15. 6.3.2 Sanofi Business Overview
  16. 6.3.3 Sanofi Lipid-lowering Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sanofi Lipid-lowering Drugs Product Portfolio
  18. 6.3.5 Sanofi Recent Developments
  19. 6.4 Novartis AG
  20. 6.4.1 Novartis AG Company Information
  21. 6.4.2 Novartis AG Business Overview
  22. 6.4.3 Novartis AG Lipid-lowering Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Novartis AG Lipid-lowering Drugs Product Portfolio
  24. 6.4.5 Novartis AG Recent Developments
  25. 6.5 Merck & Co., Inc.
  26. 6.5.1 Merck & Co., Inc. Company Information
  27. 6.5.2 Merck & Co., Inc. Business Overview
  28. 6.5.3 Merck & Co., Inc. Lipid-lowering Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck & Co., Inc. Lipid-lowering Drugs Product Portfolio
  30. 6.5.5 Merck & Co., Inc. Recent Developments
  31. 6.6 Pfizer, Inc.
  32. 6.6.1 Pfizer, Inc. Company Information
  33. 6.6.2 Pfizer, Inc. Business Overview
  34. 6.6.3 Pfizer, Inc. Lipid-lowering Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Pfizer, Inc. Lipid-lowering Drugs Product Portfolio
  36. 6.6.5 Pfizer, Inc. Recent Developments
  37. 6.7 GlaxoSmithKline plc
  38. 6.7.1 GlaxoSmithKline plc Company Information
  39. 6.7.2 GlaxoSmithKline plc Business Overview
  40. 6.7.3 GlaxoSmithKline plc Lipid-lowering Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 GlaxoSmithKline plc Lipid-lowering Drugs Product Portfolio
  42. 6.7.5 GlaxoSmithKline plc Recent Developments
  43. 6.8 Amgen Inc.
  44. 6.8.1 Amgen Inc. Company Information
  45. 6.8.2 Amgen Inc. Business Overview
  46. 6.8.3 Amgen Inc. Lipid-lowering Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Amgen Inc. Lipid-lowering Drugs Product Portfolio
  48. 6.8.5 Amgen Inc. Recent Developments
  49. 6.9 AbbVie, Inc.
  50. 6.9.1 AbbVie, Inc. Company Information
  51. 6.9.2 AbbVie, Inc. Business Overview
  52. 6.9.3 AbbVie, Inc. Lipid-lowering Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AbbVie, Inc. Lipid-lowering Drugs Product Portfolio
  54. 6.9.5 AbbVie, Inc. Recent Developments
  55. 6.10 AstraZeneca PLC
  56. 6.10.1 AstraZeneca PLC Company Information
  57. 6.10.2 AstraZeneca PLC Business Overview
  58. 6.10.3 AstraZeneca PLC Lipid-lowering Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AstraZeneca PLC Lipid-lowering Drugs Product Portfolio
  60. 6.10.5 AstraZeneca PLC Recent Developments
  61. 6.11 Viatris (Mylan N.V.)
  62. 6.11.1 Viatris (Mylan N.V.) Company Information
  63. 6.11.2 Viatris (Mylan N.V.) Business Overview
  64. 6.11.3 Viatris (Mylan N.V.) Lipid-lowering Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Viatris (Mylan N.V.) Lipid-lowering Drugs Product Portfolio
  66. 6.11.5 Viatris (Mylan N.V.) Recent Developments
  67. 6.12 Dr. Reddy’s Laboratories Ltd.
  68. 6.12.1 Dr. Reddy’s Laboratories Ltd. Company Information
  69. 6.12.2 Dr. Reddy’s Laboratories Ltd. Business Overview
  70. 6.12.3 Dr. Reddy’s Laboratories Ltd. Lipid-lowering Drugs Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Dr. Reddy’s Laboratories Ltd. Lipid-lowering Drugs Product Portfolio
  72. 6.12.5 Dr. Reddy’s Laboratories Ltd. Recent Developments
7 North America by Country
  1. 7.1 North America Lipid-lowering Drugs Sales by Country
  2. 7.1.1 North America Lipid-lowering Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Lipid-lowering Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Lipid-lowering Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Lipid-lowering Drugs Market Size by Country
  6. 7.2.1 North America Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Lipid-lowering Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Lipid-lowering Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Lipid-lowering Drugs Sales by Country
  2. 8.1.1 Europe Lipid-lowering Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Lipid-lowering Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Lipid-lowering Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Lipid-lowering Drugs Market Size by Country
  6. 8.2.1 Europe Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Lipid-lowering Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Lipid-lowering Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Lipid-lowering Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Lipid-lowering Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Lipid-lowering Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Lipid-lowering Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Lipid-lowering Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Lipid-lowering Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Lipid-lowering Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Lipid-lowering Drugs Sales by Country
  2. 10.1.1 South America Lipid-lowering Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Lipid-lowering Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Lipid-lowering Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Lipid-lowering Drugs Market Size by Country
  6. 10.2.1 South America Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Lipid-lowering Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Lipid-lowering Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Lipid-lowering Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Lipid-lowering Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Lipid-lowering Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Lipid-lowering Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Lipid-lowering Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Lipid-lowering Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Lipid-lowering Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Lipid-lowering Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Lipid-lowering Drugs Value Chain Analysis
  2. 12.1.1 Lipid-lowering Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Lipid-lowering Drugs Production Mode & Process
  7. 12.2 Lipid-lowering Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Lipid-lowering Drugs Distributors
  10. 12.2.3 Lipid-lowering Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst